Has Carol Foulds received payments from drug or device companies?

Yes. Drug and device makers reported $3,119 in general payments to Carol Foulds across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carol Foulds did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carol Foulds come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carol Foulds

Dermatology · Overland Park, KSNPI 1114954450

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2020 at $890 and has fallen 93.0% since, to $63 in 2025.

$3,119in general payments, 2019–2025

Across 146 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$787
E.r. Squibb & Sons, L.L.C.$427
Dermavant Sciences, Inc.$426
Journey Medical Corporation$254
Pfizer$238
Incyte Corporation$231
plus $755 from 13 others

What the payments were for

Food & beverage$2,97695%
Education$1435%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	28	$787
E.r. Squibb & Sons, L.L.C.	10	$427
Dermavant Sciences, Inc.	35	$426
Journey Medical Corporation	16	$254
Pfizer	10	$238
Incyte Corporation	6	$231
Galderma Laboratories, L.p.	11	$171
Dermira, Inc.	6	$130
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$88
Verrica Pharmaceuticals Inc.	4	$76
Mayne Pharma Commercial LLC	2	$52
Sun Pharmaceutical Industries Inc.	3	$51
Almirall LLC	2	$47
Prugen, Inc. Pharmaceuticals	1	$39
Lilly USA, LLC	2	$33
Aclaris Therapeutics, Inc.	2	$24
LEO Pharma Inc.	1	$19
Organon	1	$18
EPI Health, LLC	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,119 in reported general payments places this provider in the 60th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas →

Other dermatology in Overland Park

David KaplanOverland Park$489K
Meena SinghOverland Park$181K
Reba SuriOverland Park$7K
Lauren Kyle TkachukOverland Park$6K
Megan LentOverland Park$5K
Mark McCuneOverland Park$5K
Jeffery GravesOverland Park$3K
Stephen MatlockOverland Park$3K
Mitchell GibbonsOverland Park$2K
Lisa MorrisOverland Park$2K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →